We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Smart Fibers Could Allow T-Shirts to Analyze Electrolytes and Metabolites in Sweat

By LabMedica International staff writers
Posted on 23 Jan 2023
Print article
Image: The microelectronic fibers fabricated by the thermal drawing process and its fabrics for sweat sensing (Photo courtesy of Jingxuan Wu et al)
Image: The microelectronic fibers fabricated by the thermal drawing process and its fabrics for sweat sensing (Photo courtesy of Jingxuan Wu et al)

Fibers and fabrics have become an integral part of our daily lives, although much remains unchanged for them despite centuries of human progression. Nevertheless, recent advancements in the multi-material fiber drawing process have led to the development of new multifunctional, fiber-based smart fabrics. Smart fabrics make it possible to seamlessly integrate electronics, optics, biosensors, and mechanics into a thin strand of fiber that is intrinsically flexible and as thin as the human hair. Such fabrics can then be used for monitoring the vital physiological signals related to human mental and physical health.

Now, a team of researchers at Tohoku University (Sendai, Japan) has developed a microelectronic fiber with microscopic parameters that is capable of analyzing electrolytes and metabolites in sweat. The micrometer scale of the microelectronic fiber enables it to be woven into clothes for healthcare applications. The researchers developed the microelectronic fiber by leveraging the versatile thermal drawing process, in which heat is applied to draw out micro-structured fiber from its macroscopic preform. The researchers also patterned on two sensing electrodes for sodium and uric acid on the longitudinal surface of the fiber.

Mainstream photolithography and printing technology have made wearable electronics possible, although this generally requires the attachment of fairly rigid electronic patches to the existing fabrics or directly on the skin, resulting in just a small area of the body being covered. The new microelectronic fiber could pave the way for fiber-based smart clothes that offer more versatility in terms of functions, larger sensing areas, and greater comfort. The new smart fabric could revolutionize the textile and healthcare industries, according to the researchers, benefiting the overall society.

"Our breakthrough is the first successful attempt at using thermally drawn fiber in wearable bioelectronics for monitoring biochemical signatures," said Dr. Yuanyuan Guo, assistant professor at Tohoku University's Frontier Research Institute for Interdisciplinary Sciences, who led the research team.

Related Links:
Tohoku University 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.